China Hiv Diagnostics Market Size, Research, Outlook to 2035
The China HIV Diagnostics Market Size is steadily expanding and represents a strategically important segment of the country’s healthcare and public health ecosystem, encompassing rapid test kits, ELISA assays, chemiluminescence immunoassays, nucleic acid testing (NAT), and point-of-care diagnostics. The market is increasingly evolving from conventional laboratory-based screening toward high-sensitivity molecular diagnostics, automated platforms, and decentralized testing solutions.